Refurbished Cardiovascular and Cardiology Equipment Market Report 2026

The refurbished cardiovascular and cardiology equipment market size has grown strongly in recent years. It will grow from $4.64 billion in 2025 to $5.09 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to high cost of new cardiology equipment, budget constraints in hospitals, established secondary equipment markets, growing device replacement cycles, increasing healthcare infrastructure gaps.

The refurbished cardiovascular and cardiology equipment market size is expected to see strong growth in the next few years. It will grow to $7.43 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to rising focus on cost optimized care delivery, expansion of cardiac diagnostics access, higher acceptance of certified refurbished devices, growth in private cardiac clinics, increasing demand in emerging markets. Major trends in the forecast period include rising demand for certified refurbished systems, growth in cost effective cardiology equipment, expansion of warranty backed refurbished devices, higher adoption in mid tier hospitals, increase in third party refurbishment providers.

The increasing healthcare expenditure globally is anticipated to drive the growth of the refurbished cardiovascular and cardiology equipment market in the coming years. Healthcare expenditure globally refers to the total financial resources spent by governments, insurers, and individuals on healthcare services, medical technologies, and public health systems across countries. Increasing healthcare expenditure globally is rising due to aging populations, which significantly increase the prevalence of cardiovascular diseases and the demand for diagnostic imaging, interventional procedures, and long-term cardiac care. Refurbished cardiovascular and cardiology equipment supports increasing healthcare expenditure globally by allowing healthcare systems to expand cardiovascular service capacity while controlling capital spending through lower acquisition costs compared to new equipment. For example, in October 2024, according to Eurostat, a Luxembourg-based statistical office, healthcare expenditure in 2023 reached $2.03 trillion (€1,720 billion), accounting for 10% of GDP, compared with $1.96 trillion (€1,660 billion) and 9.9% of GDP in 2022. Therefore, the increasing healthcare expenditure globally is driving the growth of the refurbished cardiovascular and cardiology equipment market.

Companies operating in the refurbished cardiovascular and cardiology equipment market are focusing on developing advanced refurbishing ultrasound systems to enhance diagnostic accuracy, improve patient outcomes, reduce operational costs, and extend the lifecycle of medical equipment for healthcare providers. Refurbishing ultrasound systems refers to the process of restoring used or pre-owned ultrasound machines to a fully functional and reliable condition so they can be safely used again in medical settings. For example, in April 2024, GE Healthcare, a US-based medical technology company, launched a new refurbishing unit in Bangladesh for its A1 SURE ultrasound systems. This unit refurbishes pre-owned ultrasound devices by replacing worn components, updating software, and ensuring full functional performance, offering a one-year warranty and flexible financing options to hospitals and clinics. The refurbished systems retain the high-resolution imaging and advanced diagnostic capabilities of new devices while reducing costs, expanding access to essential cardiovascular and cardiology imaging in developing regions.

In October 2023, GE HealthCare Technologies Inc., a US‑based provider of medical technologies, pharmaceutical diagnostics, digital healthcare solutions, and full lifecycle equipment services, partnered with Relink Medical to collaborate on a standardized medical equipment disposition solution that helps healthcare providers sell, recycle, or donate end‑of‑life medical devices to reduce medical device waste and improve operational efficiency. Through this collaboration, GE HealthCare aims to enhance its asset management capabilities and support healthcare providers in managing clinical equipment throughout its lifecycle while advancing sustainability goals. ReLink Medical LLC is a US‑based provider of refurbished medical devices, including cardiovascular-related equipment.

Major companies operating in the refurbished cardiovascular and cardiology equipment market are Siemens Healthineers AG, Hitachi Ltd., Medtronic plc, Stryker Corporation, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Sanrad Medical Systems, Neusoft Medical Systems Co. Ltd., Soma Technology Inc, Diamond Diagnostics, Amber Diagnostics, Radiology Oncology Systems Inc., Master Medical Equipment, Venture Medical ReQuip Inc, EverX Pty Ltd., Whittemore Enterprises Inc., Fair Medical Co. Ltd., Future Health Concepts Inc., Jaken Medical Inc., Mediproma B.V., and PrimedeQ India Private Limited.

Tariffs on imported medical devices, electronic components, and replacement parts are increasing refurbishment and resale costs in the cardiovascular equipment market. Duties on imaging modules, monitoring electronics, and test accessories are affecting refurbished ultrasound and ECG systems most strongly. Regions dependent on imported used equipment and spare parts, especially in Africa and parts of Asia, are seeing price variability. Refurbishers are shifting toward regional parts sourcing and local service hubs. Some tariffs are encouraging domestic refurbishment operations and in country testing facilities. This is creating new local business opportunities. It is also improving turnaround time for refurbished device supply.

The refurbished cardiovascular and cardiology equipment market research report is one of a series of new reports that provides refurbished cardiovascular and cardiology equipment market statistics, including refurbished cardiovascular and cardiology equipment industry global market size, regional shares, competitors with a refurbished cardiovascular and cardiology equipment market share, detailed refurbished cardiovascular and cardiology equipment market segments, market trends and opportunities, and any further data you may need to thrive in the refurbished cardiovascular and cardiology equipment industry. This refurbished cardiovascular and cardiology equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Refurbished cardiovascular equipment includes pre-owned medical devices used for diagnosing, monitoring, and treating heart and vascular conditions that have been carefully restored, rigorously tested, recalibrated, and certified to meet original safety and performance standards for reliable clinical use. These systems provide healthcare facilities with an affordable alternative to new equipment while preserving high diagnostic and treatment precision, expanding access to advanced cardiovascular care.

The primary product types of refurbished cardiovascular and cardiology equipment include electrocardiographs, defibrillators, cardiac ultrasound systems, stress testing systems, holter monitors, and other product categories. Electrocardiographs are devices used to capture and record the heart’s electrical activity for identifying abnormalities and monitoring cardiac function. These products are offered in equipment conditions such as certified refurbished equipment, remanufactured equipment, used equipment with warranty, and pre-owned equipment. They are distributed via channels including direct sales, online sales platforms, third-party distributors, and medical equipment trade shows and are utilized by end users such as hospitals and clinics, diagnostic centers, ambulatory surgical centers, research institutions, and home care environments.

The refurbished cardiovascular and cardiology equipment market consists of sales of refurbished echocardiography systems, refurbished electrocardiography machines, refurbished cardiac catheterization laboratory systems, refurbished cardiac monitoring systems, and refurbished stress test systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.